Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

Europe - AMS:EXO - NL0012059018 - Common Stock

83.55 EUR
+0.5 (+0.6%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

5

Overall EXO gets a fundamental rating of 5 out of 10. We evaluated EXO against 46 industry peers in the Financial Services industry. EXO scores excellent on profitability, but there are some minor concerns on its financial health. EXO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

EXO had positive earnings in the past year.
In the past year EXO had a positive cash flow from operations.
EXO had positive earnings in 4 of the past 5 years.
Each year in the past 5 years EXO had a positive operating cash flow.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

The Return On Assets of EXO (34.55%) is better than 97.83% of its industry peers.
EXO's Return On Equity of 38.39% is amongst the best of the industry. EXO outperforms 89.13% of its industry peers.
The Return On Invested Capital of EXO (26.91%) is better than 95.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXO is above the industry average of 10.06%.
The last Return On Invested Capital (26.91%) for EXO is above the 3 year average (13.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROIC 26.91%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)13.67%
ROIC(5y)9.18%
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin of EXO (95.30%) is better than 97.83% of its industry peers.
In the last couple of years the Profit Margin of EXO has grown nicely.
With an excellent Operating Margin value of 96.43%, EXO belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
In the last couple of years the Operating Margin of EXO has grown nicely.
The Gross Margin of EXO (100.00%) is better than 97.83% of its industry peers.
In the last couple of years the Gross Margin of EXO has grown nicely.
Industry RankSector Rank
OM 96.43%
PM (TTM) 95.3%
GM 100%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EXO is creating value.
EXO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXO has less shares outstanding
The debt/assets ratio for EXO has been reduced compared to a year ago.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

EXO has an Altman-Z score of 5.20. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.20, EXO belongs to the best of the industry, outperforming 84.78% of the companies in the same industry.
EXO has a debt to FCF ratio of 87.02. This is a negative value and a sign of low solvency as EXO would need 87.02 years to pay back of all of its debts.
With a Debt to FCF ratio value of 87.02, EXO is not doing good in the industry: 76.09% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.08 indicates that EXO is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.08, EXO is doing good in the industry, outperforming 71.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Altman-Z 5.2
ROIC/WACC5.93
WACC4.54%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
EXO has a worse Current ratio (0.19) than 78.26% of its industry peers.
A Quick Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
EXO has a worse Quick ratio (0.19) than 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2

3. Growth

3.1 Past

EXO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 262.89%, which is quite impressive.
Measured over the past years, EXO shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.47% on average per year.
EXO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -65.59%.
The Revenue for EXO have been decreasing by -36.03% on average. This is quite bad
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
Revenue 1Y (TTM)-65.59%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-98.91%

3.2 Future

Based on estimates for the next years, EXO will show a very negative growth in Earnings Per Share. The EPS will decrease by -51.47% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-106.96%
EPS Next 2Y-55.3%
EPS Next 3Y-51.47%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.25, the valuation of EXO can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of EXO indicates a rather cheap valuation: EXO is cheaper than 93.48% of the companies listed in the same industry.
EXO is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for EXO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 1.25
Fwd PE N/A
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXO is valued cheaply inside the industry as 82.61% of the companies are valued more expensively.
EXO's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. EXO is more expensive than 78.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 369.36
EV/EBITDA 1.43
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

EXO has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as EXO's earnings are expected to decrease with -51.47% in the coming years.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2Y-55.3%
EPS Next 3Y-51.47%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.59%, EXO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.73, EXO has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, EXO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

EXO pays out 0.67% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of EXO has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0.67%
EPS Next 2Y-55.3%
EPS Next 3Y-51.47%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
EXO.AS Dividend Payout.EXO.AS Dividend Payout, showing the Payout Ratio.EXO.AS Dividend Payout.PayoutRetained Earnings

EXOR NV

AMS:EXO (9/19/2025, 7:00:00 PM)

83.55

+0.5 (+0.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-17 2025-09-17
Inst Owners26.77%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap17.36B
Analysts85
Price Target119.05 (42.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP0.67%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.37%
PT rev (3m)0.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-130.57%
EPS NY rev (3m)-130.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.25
Fwd PE N/A
P/S 1.13
P/FCF 369.36
P/OCF 369.36
P/B 0.45
P/tB 0.45
EV/EBITDA 1.43
EPS(TTM)66.88
EY80.05%
EPS(NY)-2.38
Fwd EYN/A
FCF(TTM)0.23
FCFY0.27%
OCF(TTM)0.23
OCFY0.27%
SpS74.09
BVpS183.91
TBVpS183.91
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROCE 35.89%
ROIC 26.91%
ROICexc 27.01%
ROICexgc 27.03%
OM 96.43%
PM (TTM) 95.3%
GM 100%
FCFM 0.31%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)13.67%
ROIC(5y)9.18%
ROICexc(3y)14.71%
ROICexc(5y)10.09%
ROICexgc(3y)16.03%
ROICexgc(5y)11.47%
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexcg growth 3Y82.33%
ROICexcg growth 5Y13.41%
ROICexc growth 3Y91.95%
ROICexc growth 5Y26.23%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Debt/EBITDA 0.2
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 170.63
Cash Conversion 0.32%
Profit Quality 0.32%
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 5.2
F-Score6
WACC4.54%
ROIC/WACC5.93
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
EPS Next Y-106.96%
EPS Next 2Y-55.3%
EPS Next 3Y-51.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-65.59%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-98.91%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y139.47%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.63%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-99.25%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%